01 Feb 2022
ESMO has announced today that the 2022 ESMO TAT Honorary Award is presented to Lesley K Seymour for her outstanding contributions to early drug development and innovative clinical trial methodology.
Seymour is Director of the Investigational New Drug Program and Deputy Director of the Canadian Cancer Trials Group (CCTG), which is based at Queens University in Kingston, Ontario. She is Professor of Oncology at Queens, and a Medical Oncologist at Kingston Health Sciences Centre.
She will deliver her award lecture on Monday, 7 March 2022 at TAT 2022.